Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niosomal minoxidil versus niosomal aminexil in men with androgenetic alopecia
IRCT20190621043963N1Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of minoxidil and aminexil in androgenetic alopecia (AGA) (2 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Number of hair follicles and Hair growth rate. Started Oct 2019; status: completed.
02
Drugs
minoxidilaminexil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20190621043963N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190621043963N1.